- Fee assured
- Verified this account
- Accredited endoscopist
- Inflammatory bowel disease
- Accredited endoscopist
Professor Matt Brookes is a Consultant Clinical Gastroenterologist working at the Royal Wolverhampton NHS Trust, where he has been the clinical lead for inflammatory bowel disease for 5 years until 2015. He was appointed as a consultant in 2009.
During his time in post he has facilitated a significant improvement in IBD research within the local network and more specifically his own trust. During his ten years as a consultant Gastroenterologist he has taken on the research lead role within his department and increased recruitment to clinical research trials from 30 patients per annum to over 400 patients in 2013 and 2017. He has been either chief investigator or local principle investigator on over 20 trials in the last 5 years.
He currently has 5 open interventional studies recruiting IBD patients to new drug therapy trials. He holds honorary academic positions at two local institutions, including an honorary chair at the University of Wolverhampton.
He has published over 50 academic papers in peer-reviewed press. He has supervised, or is currently supervising three post-graduate clinical fellows. His laboratory research has recently expanded, with the funding and development of a Gastroenterology academic research unit in collaboration with Wolverhampton University. This is co-led by Professor Brookes who coordinates Gastroenterology research activity within this unit.
He has received research funding of around £500,000 over the last 2 years.
He is the clinical speciality research lead for Gastroenterology within the West Midlands network.
Professor Brookes is the immediate past chair of the British Society of Gastroenterology research committee. He is also the Midlands Gastroenterological Society secretary and is a trustee for the national charity Guts UK.
Areas of interest
Endoscopy; Colonoscopy; Investigation of anaemia; Change in bowel habit; Abdominal pain; Dyspepsia; Diarrhoea; Constipation; Inflammatory bowel disease; Dyspepsia.
Current NHS consultant posts held
Consultant Gastroenterologist New Cross Hospital
Honorary Senior Lecturer at University of Birmingham
Honorary Professor of Gastroenterology
Biomarkers in IBD
Inflammatory Bowel Disease
Grants for research of approximately £500,000 in last 5 years
w. Chauhan A, Perry I, Veitch A, Li P, Rattehalli D, Brookes MJ. Gastropericardial fistula: a potential role for conservative treatment. Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1341-3.
x. Chauhan A, Perry I, Veitch A, Li P, Rattehalli D, Brookes MJ. Gastre-pericardial fistulae: is there a role for conservative management. Eur Journal of Gastroenterology Accepted.
y. Sorina Radulescu 1, Matthew J Brookes 2, Pedro Salgueiro 1, Rachel A Ridgway 1, Ewan McGhee 1, Kurt Anderson1, Samuel Ford 2, Daniel Stone 2,Tariq H Iqbal 2 , Chris Tselepis 2# and Owen J Sansom 1# Luminal iron levels govern intestinal tumourigenesis following Apc loss in vivo. Cell Rep. 2012 Aug 30;2(2):270-82. .
z. Keeler BD, Krell J, Acheson AG, Brookes MJ, Stebbing J, Frampton AE. Is there a role for intravenous iron therapy in patients undergoing colorectal cancer resection? Expert Rev Anticancer Ther. 2012 Nov;12(11):1407-12.
aa. Liu JZ, Almarri MA, Gaffney DJ, Mells GF, Jostins L, Cordell HJ, Ducker SJ, Day DB, Heneghan MA, Neuberger JM, Donaldson PT, Bathgate AJ, Burroughs A, Davies MH, Jones DE, Alexander GJ, Barrett JC, Sandford RN, Anderson CA; UK Primary Biliary Cirrhosis (PBC) Consortium; Wellcome Trust Case Control Consortium 3. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat Genet. 2012 Oct;44(10):1137-41
bb. Carbone M, Mells GF, Pells G, Dawwas MF, Newton JL, Heneghan MA, Neuberger JM, Day DB, Ducker SJ; UK PBC Consortium, et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology. 2013 Mar;144(3):560-569.
cc. Whitehead SJ, French J, Brookes MJ, Ford C, Gama R. Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits. Ann Clin Biochem. 2013 Jan;50(Pt 1):53-61.
dd. Pells G, Mells GF, Carbone M, Newton JL, UK PBC Consortium et al. The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort. J Hepatol. 2013 Jul;59(1):67-73.
ee. Keeler BD, Brookes MJ. Iron chelation: a potential therapeutic strategy in oesophageal cancer. Br J Pharmacol. 2013 Mar;168(6):1313-5.
ff. Padmanabhan H, Iqbal T and Brookes MJ. Iron & colorectal cancer in 2013; evidence from in vitro and animal studies. Nutr Reviews. Under review 2014.
Courses offered to GPs
Regular educational events to primary care teams undertaken.
Colonoscopy completion rate of 97% in last 12 months
At last satisfaction survey - 100% customer satisfaction
- MBChB Bristol University 1991
- FRCP RCP London 2013
- PhD Birmingham University 2009
Reference number 4370882
Professional bodies (positions held - last 3 yrs)
- FRCP RCP London 2013
Details of entry to specialist register
- CCST Entry, 2009
Affiliations / memberships
Midlands Gastro Society
British Society of Gastroenterology
BSG Small bowel clinical studies group
West Midlands Research Lead for Gastroenterology
Chair of the BSG Research Committee
Trustees and research awards committee member to CORE charity
Secretary of the MGS
- Nuffield Health Wolverhampton Hospital, WV6 8LE
- 12:30 - 19:00
- 01902 793225
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.